Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study
Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study have?
Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study published?
Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study has 2026 year in the ScholarIQ index.
What is the open-access status of Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study?
Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study has gold oa status in the ScholarIQ index.
What is the DOI of Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study?
The DOI for Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study is on the source record.
What is the PMID of Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study?
The PMID for Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study is on the source record.
What is the OpenAlex record for Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study?
The OpenAlex for Insulin resistance surrogate indices and incident cardiovascular disease across cardiovascular–kidney–metabolic stages 0–3: a prospective cohort study is on the source record.